retatrutide glp-1 gip glucagon agonist Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide

[2] [3] Based on the known class effects of GLP-1 and GIP receptor agonists, the following additional cautions are relevant, even where retatrutide-specific data are still emerging: Acute pancreatitis : Participants should be advised to seek urgent medical attention if they develop severe, persistent abdominal pain particularly pain radiating to the back accompanied by vomiting, as this may indicate pancreatitis

Kubota T, Shoda K, Ushigome E, Kosuga T, Konishi H, Shiozaki A, et al

GLP-1 Injections A GLP-1 injection is often used to help manage type 2 diabetes and can lead to more manageable weight loss

BMI categories and obesity classifications explained Before diving deeper into eligibility specifics, it helps to understand exactly where each BMI number places you in the medical classification system